Author

Vincent Joustra

PERIPHERAL BLOOD DNA METHYLATION PROFILES PREDICT RESPONSE TO USTEKINUMAB AND SHOW STABILITY DURING BOTH INDUCTION AND MAINTENANCE TREATMENT IN CROHN’S DISEASE
PERIPHERAL BLOOD DNA METHYLATION PROFILES PREDICT RESPONSE TO USTEKINUMAB AND SHOW STABILITY DURING BOTH INDUCTION AND MAINTENANCE TREATMENT IN CROHN’S DISEASE

Vincent Joustra  et al.

PERIPHERAL BLOOD DNA METHYLATION PROFILES PREDICT RESPONSE TO USTEKINUMAB AND SHOW STABILITY DURING BOTH INDUCTION AND MAINTENANCE TREATMENT IN CROHN’S DISEASE
PERIPHERAL BLOOD DNA METHYLATION PROFILES PREDICT RESPONSE TO USTEKINUMAB AND SHOW STABILITY DURING BOTH INDUCTION AND MAINTENANCE TREATMENT IN CROHN’S DISEASE

NATURAL HISTORY OF RECURRENT CROHN'S DISEASE FOLLOWING ILEOCOLONIC RESECTION: A MULTICENTER RETROSPECTIVE CROSS-SECTIONAL COHORT STUDY
NATURAL HISTORY OF RECURRENT CROHN'S DISEASE FOLLOWING ILEOCOLONIC RESECTION: A MULTICENTER RETROSPECTIVE CROSS-SECTIONAL COHORT STUDY

Vincent Joustra  et al.

MUCOSA-ASSOCIATED MICROBIAL SIGNATURES DISCRIMINATE RESPONSE TO BIOLOGICALS IN CROHN’S DISEASE
MUCOSA-ASSOCIATED MICROBIAL SIGNATURES DISCRIMINATE RESPONSE TO BIOLOGICALS IN CROHN’S DISEASE

Vincent Joustra  et al.

SINGLE-CELL TRANSCRIPTOMICS IN PERIPHERAL BLOOD MONONUCLEAR CELLS REVEALS CELL POPULATION DIFFERENCES THAT DEFINE VEDOLIZUMAB RESPONSE AMONG CD PATIENTS
SINGLE-CELL TRANSCRIPTOMICS IN PERIPHERAL BLOOD MONONUCLEAR CELLS REVEALS CELL POPULATION DIFFERENCES THAT DEFINE VEDOLIZUMAB RESPONSE AMONG CD PATIENTS

Vincent Joustra  et al.

RESPONSE TO TOFACITINIB IN ULCERATIVE COLITIS PREDICTED BY A MACHINE-LEARNING ALGORITHM; A MULTI-OMICS APPROACH
RESPONSE TO TOFACITINIB IN ULCERATIVE COLITIS PREDICTED BY A MACHINE-LEARNING ALGORITHM; A MULTI-OMICS APPROACH

Vincent Joustra  et al.

Item 1 - 6 / 6
1